These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The selective determination of potentially carcinogenic polycyclic aromatic compounds in lubricant base oils by the DMSO extraction method IP346 and its correlation to mouse skin painting carcinogenicity assays. Carrillo JC; van der Wiel A; Danneels D; Kral O; Boogaard PJ Regul Toxicol Pharmacol; 2019 Aug; 106():316-333. PubMed ID: 31103638 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of the epidermal carcinogenic potential of cutting fluids. McKee RH; Scala RA; Chauzy C J Appl Toxicol; 1990 Aug; 10(4):251-6. PubMed ID: 2391406 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the dermal carcinogenicity of lubricant base oils by the mouse skin painting bioassay and other proposed methods. Chasey KL; McKee RH J Appl Toxicol; 1993; 13(1):57-65. PubMed ID: 8440875 [TBL] [Abstract][Full Text] [Related]
5. Carcinogenic potential of hydrotreated petroleum aromatic extracts. Doak SM; Hend RW; van der Wiel A; Hunt PF Br J Ind Med; 1985 Jun; 42(6):380-8. PubMed ID: 4005190 [TBL] [Abstract][Full Text] [Related]
7. DNA adducts produced by oils, oil fractions and polycyclic aromatic hydrocarbons in relation to repair processes and skin carcinogenesis. Ingram AJ; Phillips JC; Davies S J Appl Toxicol; 2000; 20(3):165-74. PubMed ID: 10797468 [TBL] [Abstract][Full Text] [Related]
8. Correlation of mutagenic and dermal carcinogenic activities of mineral oils with polycyclic aromatic compound content. Roy TA; Johnson SW; Blackburn GR; Mackerer CR Fundam Appl Toxicol; 1988 Apr; 10(3):466-76. PubMed ID: 3286347 [TBL] [Abstract][Full Text] [Related]
9. Quantification of the carcinogenic effect of polycyclic aromatic hydrocarbons in used engine oil by topical application onto the skin of mice. Grimmer G; Dettbarn G; Brune H; Deutsch-Wenzel R; Misfeld J Int Arch Occup Environ Health; 1982; 50(1):95-100. PubMed ID: 7085089 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the dermal carcinogenic potential of tar sands bitumen-derived liquids. McKee RH; Stubblefield WA; Lewis SC; Scala RA; Simon GS; DePass LR Fundam Appl Toxicol; 1986 Aug; 7(2):228-35. PubMed ID: 3758541 [TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity of petroleum lubricating oil distillates: effects of solvent refining, hydroprocessing, and blending. Halder CA; Warne TM; Little RQ; Garvin PJ Am J Ind Med; 1984; 5(4):265-74. PubMed ID: 6720690 [TBL] [Abstract][Full Text] [Related]
12. Petroleum mineral oil refining and evaluation of cancer hazard. Mackerer CR; Griffis LC; Grabowski JS; Reitman FA Appl Occup Environ Hyg; 2003 Nov; 18(11):890-901. PubMed ID: 14555442 [TBL] [Abstract][Full Text] [Related]
13. Skin tumorigenic potential of crude and refined coal liquids and analogous petroleum products. Witschi HP; Smith LH; Frome EL; Pequet-Goad ME; Griest WH; Ho CH; Guerin MR Fundam Appl Toxicol; 1987 Aug; 9(2):297-303. PubMed ID: 3653572 [TBL] [Abstract][Full Text] [Related]
14. Chronic dermal studies of petroleum streams in mice. Broddle WD; Dennis MW; Kitchen DN; Vernot EH Fundam Appl Toxicol; 1996 Mar; 30(1):47-54. PubMed ID: 8812220 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the dermal carcinogenic potential of re-refined base stocks using the modified Ames assay, PAC analysis and the 32P-postlabeling assay for DNA adduct induction. Dickson JR; Brinkman DW; Blackburn GR J Appl Toxicol; 1997; 17(2):113-7. PubMed ID: 9183054 [TBL] [Abstract][Full Text] [Related]
17. Comparative dermal carcinogenesis of shale and petroleum-derived distillates. Clark CR; Walter MK; Ferguson PW; Katchen M Toxicol Ind Health; 1988 Mar; 4(1):11-22. PubMed ID: 3388444 [TBL] [Abstract][Full Text] [Related]
18. Toxicological characteristics of refinery streams used to manufacture lubricating oils. Kane ML; Ladov EN; Holdsworth CE; Weaver NK Am J Ind Med; 1984; 5(3):183-200. PubMed ID: 6702826 [TBL] [Abstract][Full Text] [Related]
19. Paving asphalt products exhibit a lack of carcinogenic and mutagenic activity. Goyak KO; McKee RH; Minsavage GD; McGowan C; Daughtrey WC; Freeman JJ Int J Toxicol; 2011 Oct; 30(5):492-7. PubMed ID: 21878556 [TBL] [Abstract][Full Text] [Related]